Levonee M Kid is a specialized fixed-dose combination medication manufactured by Amista Labs. Designed primarily for pediatric use, this tablet combines two potent active ingredients—Levocetrizine Hydrochloride (2.5 mg) and Montelukast Sodium (4 mg)—to provide a multi-channel approach to managing allergic conditions and respiratory issues.
Levocetrizine Hydrochloride IP 2.5mg + Montelukast IP 4mg
The efficacy of Levonee M Kid stems from its dual-action formula. Each component targets a different pathway of the allergic response:
Levocetrizine Hydrochloride (2.5 mg): This is a second-generation antihistamine. It works by blocking histamine, a natural substance in the body that causes allergic symptoms like itching, sneezing, and runny nose. Unlike older antihistamines, Levocetrizine is known for being highly selective, meaning it provides relief with a significantly lower risk of drowsiness.
Montelukast Sodium (4 mg): This is a leukotriene receptor antagonist. Leukotrienes are chemicals the body releases when you breathe in an allergen (like pollen). They cause swelling in the lungs and tightening of the muscles around the airways. By blocking these, Montelukast helps improve asthma symptoms and prevents the “narrowing” of airways during exercise or allergic reactions.
As highlighted in the product documentation, Levonee M Kid is indicated for a variety of conditions that affect the respiratory system and the skin:
Allergic Rhinitis (Seasonal & Perennial): It effectively treats “hay fever” symptoms, including sneezing, nasal congestion, and watery eyes.
Chronic Urticaria: It helps manage chronic hives, reducing the redness, swelling, and intense itching associated with skin allergies.
Asthma Management: While not a “rescue” inhaler for acute attacks, it is used as a long-term controller to keep airway inflammation down.
Exercise-Induced Bronchoconstriction (EIB): It prevents the narrowing of airways that occurs specifically during or after physical exertion.
Allergic Asthma: It is particularly useful for patients whose asthma symptoms are triggered by environmental allergens.
The “Kid” designation indicates that this specific formulation is tailored for children, typically in the age range where a 2.5 mg / 4 mg ratio is appropriate.
Important Note: Dosage must be determined by a qualified pediatrician. It is usually administered once daily, often in the evening, as Montelukast is typically most effective when taken before sleep to manage nighttime asthma and morning allergy symptoms.
Amista Labs emphasizes quality through several international and national certifications visible on their product profile:
WHO-GMP Certified: Ensures the product is consistently produced and controlled according to quality standards.
GLP (Good Laboratory Practice): Indicates rigorous testing and laboratory reliability.
ISO 9001:2015: A testament to the company’s quality management systems.
| Feature | Detail |
| Product Name | Levonee M Kid Tablet |
| Manufacturer | Amista Labs |
| Packing | 10×10 (Alu Alu) – Total 100 tablets per box |
| MRP | 703.13/- per Box |
| Category | General Practitioner (GP), ENT, Allergy |
While Levonee M Kid is generally well-tolerated, parents should monitor for potential side effects such as mild headache, dry mouth, or fatigue. Because it contains Montelukast, it is vital to report any unusual changes in mood or behavior to a doctor immediately.
Levonee M Kid represents a balanced therapeutic option for children struggling with the dual burden of allergies and asthma, offering a single-tablet solution to improve compliance and quality of life.
Users Today : 14
Users Yesterday : 61
Users This Month : 969
Users This Year : 2147Am Wiesental 5, 76829, Landau in der Pfalz, Germany
Plot No. 633, JLPL Industrial Park, Sector 82, S.A.S Nagar (Mohali) Punjab, 160055
This will close in 0 seconds

